Efficacy of melatonin treatment in a phase advance model of insomnia
褪黑素治疗失眠阶段进展模型的疗效
基本信息
- 批准号:8468010
- 负责人:
- 金额:$ 29.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAddressAffectAgonistArousalBiological ClocksBody TemperatureCircadian Rhythm Sleep DisordersCircadian RhythmsDelayed Sleep Phase SyndromeDevelopmentDiseaseDoseEvidence based treatmentExposure toEyeFood SupplementsGastrointestinal DiseasesGeneral PopulationHealthHormonesHourHumanHydrocortisoneIndividualJet Lag SyndromeLaboratoriesLeadLightMaintenanceMeasuresMelatoninMeta-AnalysisMethodsModelingNorth AmericaOutcomePathway interactionsPerformancePhasePhase response curvesPhysiologicalPineal glandPlacebosPlasmaPrimary InsomniaProcessPropertyRandomized Controlled TrialsReportingResearch PersonnelSafetyScheduleSimulateSleepSleep DisordersSleep Wake CycleSleeplessnessSupplementationSystemTestingTimeTransient InsomniaTravelUnited StatesVisually Impaired PersonsWakefulnessalertnessawakebasecircadian pacemakercosteffective therapyexperienceheart disease riskimprovedpressureshift worksleep onsetsuprachiasmatic nucleussystematic reviewtreatment duration
项目摘要
Melatonin is a hormone produced by the pineal gland at night. The timing of its release is controlled
by the circadian timing system. Its timing can be suppressed or reset by exposure to light through a
multisynaptic pathway from the eye through the suprachiasmatic nucleus, the master circadian clock.
Exogenous melatonin supplementation has been reported to act in two ways in humans: as a soporific
(sleep-promoting) and a chronobiotic (to reset circadian phase), thus affecting both of the
neurobiologic systems that interact to regulate sleep and wakefulness. Melatonin supplements have
been reported to be an effective treatment for circadian rhythm sleep disorders, including shift work
dyssomnia, jet-lag, delayed sleep phase syndrome, and sleep disruption suffered by many blind
individuals. However, in a recent meta-analysis, the vast majority of these reports were excluded
because they were not randomized controlled trials. The conclusion was that melatonin is not
efficacious for sleep complaints associated with jetlag and shift work. In view of the widespread,
uncontrolled, over-the-counter use of melatonin for treating sleep complaints in the general
population, a randomized controlled trial of melatonin is essential to evaluate efficacy in treatment of
transient insomnia.
The current proposal will test the chronobiotic and sleep promoting effects of melatonin in a phase
advance model of insomnia. Subjects will be administered either melatonin or placebo before a
scheduled sleep episode which is advanced by several hours, simulating eastward travel. Under
these conditions, low sleep pressure and the timing of the circadian clock make sleep particularly
difficult. We will measure sleep and multiple physiologic rhythms controlled by the circadian after
melatonin or placebo administration, and use precise analytic methods to determine the impact of
melatonin on sleep and the human circadian timing system. This study will provide important
information regarding the mechanism of action of melatonin that will be critical for the use of melatonin
as a treatment for circadian rhythm sleep disorders.
褪黑激素是松果体在夜间产生的一种激素。其发布的时间受到控制
昼夜节律计时系统。它的计时可以通过暴露在光线中来抑制或重置
多突触通路从眼睛通过视交叉上核,主生物钟。
据报道,外源性褪黑激素补充剂在人类中以两种方式起作用:
(促进睡眠)和时间生物素(重置昼夜节律),从而影响两个
神经生物系统相互作用来调节睡眠和觉醒。褪黑激素补充剂
据报道,它是一种有效的治疗昼夜节律睡眠障碍,包括轮班工作
许多盲人患有精神障碍、时差反应、睡眠期延迟综合征和睡眠中断,
个体然而,在最近的荟萃分析中,这些报告中的绝大多数被排除在外
因为它们不是随机对照试验。结论是褪黑激素
有效的睡眠投诉与时差和轮班工作。鉴于普遍存在的,
不受控制的,非处方使用褪黑激素治疗睡眠投诉,
人群中,褪黑激素的随机对照试验是必不可少的,以评估治疗效果
短暂性失眠
目前的提议将在一个阶段测试褪黑激素的生物钟和睡眠促进作用
失眠症的先进模型受试者将在治疗前施用褪黑激素或安慰剂。
提前几个小时的预定睡眠片段,模拟向东旅行。下
这些条件,低睡眠压力和生物钟的定时使睡眠特别
难我们将测量睡眠和多种生理节律控制的昼夜节律后,
褪黑激素或安慰剂给药,并使用精确的分析方法来确定
褪黑激素对睡眠和人体昼夜节律计时系统的影响。这项研究将提供重要的
关于褪黑激素作用机制的信息,这对于褪黑激素的使用至关重要
作为昼夜节律睡眠障碍的治疗方法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeanne F Duffy其他文献
Feasibility, effectiveness, and acceptability of an afternoon-evening sleep schedule in older nightshift workers
老年夜班工人下午-晚上睡眠时间表的可行性、有效性和可接受性
- DOI:
10.1093/sleepadvances/zpae010 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
L. Barger;Yuan Zhang;Heidi M Lammers;Davina Snoep;Audra S Murphy;B. Desnoyers;Jeanne F Duffy - 通讯作者:
Jeanne F Duffy
Jeanne F Duffy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeanne F Duffy', 18)}}的其他基金
Proteomic and Transcriptomic Biomarkers of Circadian Timing
昼夜节律的蛋白质组和转录组生物标志物
- 批准号:
10461968 - 财政年份:2020
- 资助金额:
$ 29.92万 - 项目类别:
Proteomic and Transcriptomic Biomarkers of Circadian Timing
昼夜节律的蛋白质组和转录组生物标志物
- 批准号:
10705083 - 财政年份:2020
- 资助金额:
$ 29.92万 - 项目类别:
Treatment of Circadian Disruption from Shiftwork in Older Adults
老年人轮班工作造成的昼夜节律紊乱的治疗
- 批准号:
10343696 - 财政年份:2019
- 资助金额:
$ 29.92万 - 项目类别:
Treatment of Circadian Disruption from Shiftwork in Older Adults
老年人轮班工作造成的昼夜节律紊乱的治疗
- 批准号:
9890984 - 财政年份:2019
- 资助金额:
$ 29.92万 - 项目类别:
Treatment of Circadian Disruption from Shiftwork in Older Adults
老年人轮班工作造成的昼夜节律紊乱的治疗
- 批准号:
8849330 - 财政年份:2013
- 资助金额:
$ 29.92万 - 项目类别:
Treatment of Circadian Disruption from Shiftwork in Older Adults
老年人轮班工作造成的昼夜节律紊乱的治疗
- 批准号:
8481650 - 财政年份:2013
- 资助金额:
$ 29.92万 - 项目类别:
Disrupted Sleep in the Elderly: Circadian Etiology
老年人睡眠中断:昼夜节律病因学
- 批准号:
7847763 - 财政年份:2009
- 资助金额:
$ 29.92万 - 项目类别:
GENETIC ANALYSIS OF EXTREME CIRCADIAN/SLEEP PHENOTYPES
极端昼夜节律/睡眠表型的遗传分析
- 批准号:
7719368 - 财政年份:2008
- 资助金额:
$ 29.92万 - 项目类别:
EFFECT OF VITAMIN B12 ON THE HUMAN CIRCADIAN TIMING SYSTEM
维生素 B12 对人体昼夜节律系统的影响
- 批准号:
7719335 - 财政年份:2008
- 资助金额:
$ 29.92万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.92万 - 项目类别:
Research Grant














{{item.name}}会员




